BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide consisting of 15 amino acids. It was originally isolated from human gastric juice and has been studied across a range of preclinical models, making it one of the more extensively researched peptides in this category.

How It Works

BPC-157 enhances growth hormone receptor expression and modulates several pathways involved in cell growth and angiogenesis while reducing inflammatory cytokines. One of its more studied properties is its influence on new blood vessel formation — research has shown upregulation of VEGFR2 expression in response to BPC-157, suggesting a role in promoting vascular growth signaling.

Where the Research Stands

The bulk of BPC-157 research has been conducted in preclinical animal models. Across multiple studies, BPC-157 improved outcomes in inflammatory bowel disease, GI ulcer, NSAID-induced injury, and wound repair models. More recently, interest has expanded into musculoskeletal research — preclinical studies consistently highlight its potential to accelerate tendon, muscle, and ligament healing, even under compromised conditions.

Product Details

Form: Lyophilized powder
Size: 10mg per vial
Purity: ≥99% | COA available on request
Storage: Keep dry and away from light before reconstitution. Refrigerate after reconstitution.

Research Use Only

BPC-157 is intended strictly for laboratory research by qualified professionals. It is not FDA approved and is not for human or animal use. By purchasing, the buyer confirms the product will be used solely for in vitro research in compliance with all applicable laws and regulations.